Window of Opportunity in the Treatment of Rheumatoid Arthritis - Interstitial Lung Disease with Abatacept. National Multicenter Study of 526 Patients

被引:0
|
作者
Serrano-Combarro, Ana [1 ]
Atienza-Mateo, Belen [2 ]
Paino, Libe Ibarrola [3 ]
Casafont-Sole, Ivette [4 ]
Loarce, Jesus [5 ]
Blanco Madrigal, Juan Maria [6 ]
Castaneda, Santos [7 ]
Ortega-Castro, Rafaela [8 ]
Mena Vazquez, Natalia
Vegas Revenga, Nuria [9 ,10 ]
Dominguez Casas, Lucia [11 ]
Peralta Gines, Cilia [12 ]
Retuerto Guerrero, Miriam [13 ]
Perez Albadalejo, Lorena [14 ]
Lopez Sanchez, Ruben [15 ]
Manzano Canabal, Maria Guadalupe [16 ]
Brandy-Garcia, Anahy Maria [17 ]
Lopez Viejo, Patricia [18 ]
Bonilla, Gema [19 ]
Maiz Alonso, Olga [20 ]
Carrasco-Cubero, Carmen [21 ]
Garijo Bufort, Marta [22 ]
Urruticoechea Arana, Ana [23 ]
Ordonez, Sergi [24 ]
Gonzalez Montagut, Carmen [25 ]
Garcia-Valle, Andrea [26 ]
Ramon De Dios, Juan [27 ]
Martin Lopez, Maria [28 ]
Vazquez Rodriguez, Tomas [29 ]
Fernandez-Lozano, Delia [30 ]
Brana Abascal, Ignacio [31 ]
Melero-Gonzalez, Rafael Benito [32 ]
Giner, Emilio [33 ]
Ruiz-Esquide, Virginia [34 ]
Ventin Rodriguez, Clara [35 ]
Rodriguez, Marina [36 ]
Andujar-Brazal, Pablo [37 ]
Fernandez Melon, Julia
Lopez-Nunez, Lilian M. [38 ]
Lamua Riazuelo, Jose Ramon [39 ]
Pamies Corts, Anna [40 ]
Fernandez Diaz, Carlos [41 ]
Loricera, Javier [42 ]
Ferrer, Diego [43 ]
Blanco-Alonso, Ricardo [44 ]
机构
[1] Hosp Univ Marques Valdecilla, IDIVAL, Santander, Cantabria, Spain
[2] Hosp Univ Marques Valdecilla, Div Rheumatol, IDIVAL, Immunopathol Grp, Santander, Spain
[3] Bisadoa Hosp, Div Rheumatol, Bidasoa, Spain
[4] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
[5] Ramon y Cajal Univ Hosp, Madrid, Spain
[6] Basurto Univ Hosp, Bilbao, Spain
[7] Hosp Univ Princesa, Madrid, Spain
[8] Hosp Reina Sofia, Cordoba, Spain
[9] IBIMA, Malaga, Spain
[10] Hosp Galdakao Usansolo, Galdakao, Spain
[11] Hosp Univ San Agustin, Aviles, Spain
[12] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain
[13] Complejo Asistencial Univ, Leon, Spain
[14] Univ Jaen, Jaen, Spain
[15] Hosp Univ Gran Canaria Dr Negrin, Gran Canaria, Spain
[16] CAZA, Salamanca, Spain
[17] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
[18] Hosp Severo Ochoa, Madrid, Spain
[19] H Univ La Paz, Madrid, Spain
[20] Hosp Univ Donosti, Donosti, Spain
[21] Complejo Hosp Univ Badajoz, Badajoz, Spain
[22] Hosp Sagunto, Valencia, Spain
[23] Hosp Son Espases, Palma De Mallorca, Spain
[24] Hosp Univ Arnau Vilanova Lleida, Lleida, Spain
[25] Univ Valladolid, Valladolid, Spain
[26] Hosp Gen Rio Carrion, Palencia, Spain
[27] Osakidetza, Vitoria, Spain
[28] Gen Univ Hosp Ciudad Real, Mexico City, DF, Mexico
[29] Complejo Hosp Univ Ferrol, Ferrol, Spain
[30] Hosp Clin Univ Valencia, Valencia, Spain
[31] Hosp Univ Cent Asturias, Oviedo, Spain
[32] CHU Ourense, Carballino, Spain
[33] Hosp Royo Villanova, Teruel, Spain
[34] Hosp Clin Barcelona, Barcelona, Spain
[35] Complejo Hosp Univ Coruna, La Coruna, Spain
[36] Hosp Clin Univ Santiago, La Coruna, Spain
[37] Hosp Univ Doctor Peset, Valencia, Spain
[38] Hosp Univ Son Llatzer, Palma De Mallorca, Spain
[39] Hosp Univ Henares, Madrid, Spain
[40] Hosp Verge Cinta, Tarragona, Spain
[41] Hosp Univ Santa Lucia, Cartagena, Spain
[42] Hosp Univ Marques Valdecilla, IDIVAL, Santander, Spain
[43] Hosp Univ Marques Valdecilla, Div Pneumol, Santander, Spain
[44] Hosp Univ Marques Valdecilla, Immunopathol Grp, Div Rheumatol, IDIVAL, Santander, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2262
引用
收藏
页码:4548 / 4550
页数:3
相关论文
共 50 条
  • [21] THE SAFETY AND TREATMENT EFFICACY OF ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS WITH INTERSTITIAL LUNG DISEASE: FROM THE TSURUMAI BIOLOGICS COMMUNICATION REGISTRY (TBCR) MULTICENTER STUDY
    Hirabara, S.
    Kojima, T.
    Takahashi, N.
    Kaneko, A.
    Kida, D.
    Hirano, Y.
    Ishiguro, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 455 - 455
  • [22] Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients
    Nakashita, Tamao
    Ando, Katsutoshi
    Takahashi, Kazuhisa
    Motojima, Shinji
    RESPIRATORY INVESTIGATION, 2016, 54 (05) : 376 - 379
  • [23] Rituximab in Rheumatoid Arthritis with Interstitial Lung Disease: A Multicenter Study of 32 Patients
    Fernandez-Diaz, Carlos
    Reina, Delia
    Rubio-Munoz, Paula
    Urruticoechea-Arana, Ana
    Carrasco-cubero, Maria
    Martin-Lopez, Maria
    Miranda-Filloy, Jose A.
    Villa-Blanco, Ignacio
    Milena Millan, Ana
    Castellvi, Ivan
    Maiz-Alonso, Olga
    Juan, Antonio
    Alvarez Reyes, Fatima
    Luis Martin-Varillas, Jose
    Vegas-Revenga, Nuria
    Blanco, Ricardo
    Angel Gonzalez-Gay, Miguel
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [24] EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS.
    Rodriguez, R. Redondo
    Godoy-Navarrete, F.
    Morales-Garrido, P.
    Rojas-Gimenez, M.
    Romero-Barco, C. M.
    Mena-Vazquez, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 599 - 599
  • [25] Does a window of opportunity for rheumatoid arthritis-associated interstitial lung disease exist?
    Akiyama, Mitsuhiro
    Alshehri, Waleed
    Kaneko, Yuko
    AUTOIMMUNITY REVIEWS, 2024, 23 (02)
  • [26] RITUXIMAB IN RHEUMATOID ARTHRITIS WITH INTERSTITIAL LUNG DISEASE: A MULTICENTER STUDY
    Fernandez-Diaz, C.
    Martin-Lopez, M.
    Carrasco-Cubero, M.
    Reina-Sanz, D.
    Rubio-Munoz, P.
    Urruticoechea-Arana, A.
    Miranda-Filloy, J.
    Vegas-Revenga, N.
    Dominguez-Casas, L.
    Gonzalez-Gay, M.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 569 - 570
  • [27] Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients
    Lopez-Maraver, Marta
    Serrano-Combarro, Ana
    Atienza-Mateo, Belen
    del Val, Natividad
    Casafont-Sole, Ivette
    Melero-Gonzalez, Rafael B.
    Perez-Linaza, Alba
    Gutierrez, Jerusalem Calvo
    Mena-Vazquez, Natalia
    Vegas-Revenga, Nuria
    Dominguez-Casas, Lucia
    Martos, Jesus Loarce
    Gines, Cilia Amparo Peralta
    Morrondo, Carolina Diez
    Albaladejo, Lorena Perez
    Sanchez, Ruben Lopez
    Canabal, Ma Guadalupe Manzano
    Brandy-Garcia, Anahy Ma
    Viejo, Patricia Lopez
    Bonilla, Gema
    Maiz-Alonso, Olga
    Carrasco-Cubero, Carmen
    Bufort, Marta Garijo
    Moreno, Mireia
    Urruticoechea-Arana, Ana
    Ordonez-Palau, Sergio
    Gonzalez-Montagut, Carmen
    Serret, Emilio Giner
    De Aberasturi, Juan Ramon De Dios Jimenez
    Morillo, Fernando Lozano
    Rodriguez, Tomas Vazquez
    Carreira, Patricia E.
    Madrigal, Juan Maria Blanco
    Ibanez, Belen Miguel
    Lopez, Marina Rodriguez
    Fernandez-Diaz, Carlos
    Loricera, Javier
    Ferraz-Amaro, Ivan
    Ferrer-Pargada, Diego
    Castaneda, Santos
    Blanco, Ricardo
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 68
  • [28] Validation of minimal disease activity for rheumatoid arthritis patients treated with the biologic therapy abatacept.
    Wells, George A.
    Boers, Maarten
    Li, Tracy
    Tugwell, Peter
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S384 - S385
  • [29] Comparison of the Efficacy and Safety of Abatacept in Rheumatoid Arthritis Patients with and Without Interstitial Lung Disease
    Sasaki, Sho
    Ishii, Akira
    Sugiyama, Mai
    Izumi, Yuto
    Nakagome, Yoko
    Hirano, Kazuki
    Kurabayashi, Takayoshi
    Sasaki, Noriko
    Yamada, Chiho
    Sato, Shinji
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [30] REFRACTORY RHEUMATOID ARTHRITIS WITH INTERSTITIAL LUNG DISEASE: COULD ABATACEPT BE THE ANSWER?
    Hayes, Fiona
    Oestoer, Andrew
    RHEUMATOLOGY, 2014, 53 : 65 - 65